Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.
Fernandez-Fernandez, B., Sarafidis P., Kanbay M., Navarro-González J. F., Soler M. José, Gorriz J. Luis, et al. (2020).  SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia.. Clin Kidney J. 13(5), 728-733.
Piperidou, A., Loutradis C., & Sarafidis P. (2020).  SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives.. J Hum Hypertens.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 35(10), 1825.
Imprialos, K., Faselis C., Boutari C., Stavropoulos K., Athyros V., Karagiannis A., et al. (2017).  SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.. Curr Pharm Des. 23(10), 1510-1521.
Arabatzis, M., & Velegraki A. (2013).  Sexual reproduction in the opportunistic human pathogen Aspergillus terreus.. Mycologia. 105(1), 71-9.
Salonia, A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., Hatzimouratidis K., et al. (2017).  Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 14(3), 297-315.
Salonia, A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., Hatzimouratidis K., et al. (2017).  Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 14(3), 285-296.
Karakasi, M-V., Vasilikos E., Voultsos P., Vlachaki A., & Pavlidis P. (2017).  Sexual homicide: Brief review of the literature and case report involving rape, genital mutilation and human arson.. J Forensic Leg Med. 46, 1-10.
Koutsampasopoulos, K., Ziakas A., & Vogiatzis I. (2017).  Sexual function of patients with heart failure: distinct phenotypes, distinct sexual function?. ESC Heart Fail. 4(3), 319.
Mykoniatis, I., Grammatikopoulou M. G., Bouras E., Karampasi E., Tsionga A., Kogias A., et al. (2018).  Sexual Dysfunction Among Young Men: Overview of Dietary Components Associated With Erectile Dysfunction.. J Sex Med. 15(2), 176-182.
Amram, N., Hacohen-Kleiman G., Sragovich S., Malishkevich A., Katz J., Touloumi O., et al. (2016).  Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.. Mol Psychiatry. 21(10), 1467-76.
Tziomalos, K., Giampatzis V., Baltatzi M., Efthymiou E., Psianou K., Papastergiou N., et al. (2014).  Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients.. J Clin Hypertens (Greenwich). 16(4), 309-12.
Polyzos, S. A., Kountouras J., Tsatsoulis A., Zafeiriadou E., Katsiki E., Patsiaoura K., et al. (2013).  Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease.. Hormones (Athens). 12(3), 405-16.
Papaioannidou, P., Skoumpa K., Michailidou M., Bostanitis C., Gara S., & Tsalidou M. (2023).  Sex related differences in anti-SARS-CoV-2-Spike IgG antibodies developed after COVID 19 vaccination. British Journal of Pharmacology. 180,
Hinkelmann, K., Botzenhardt J., Muhtz C., Agorastos A., Wiedemann K., Kellner M., et al. (2012).  Sex differences of salivary cortisol secretion in patients with major depression.. Stress. 15(1), 105-9.
Kallianos, A., Panoutsopoulos A., Mermigkis C., Kostopoulos K., Papamichail C., Kokkonouzis I., et al. (2015).  Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome.. Clin Interv Aging. 10, 1361-6.
Gebhard, C., Fiechter M., Herzog B. A., Lohmann C., Bengs S., Treyer V., et al. (2018).  Sex differences in the long-term prognostic value of N-ammonia myocardial perfusion positron emission tomography.. Eur J Nucl Med Mol Imaging. 45(11), 1964-1974.
Bozikas, V. P., Kosmidis M. H., Peltekis A., Giannakou M., Nimatoudis I., Karavatos A., et al. (2010).  Sex differences in neuropsychological functioning among schizophrenia patients.. Aust N Z J Psychiatry. 44(4), 333-41.
Fountoulakis, K. N., & Gonda X. (2020).  Sex differences in maturation and aging of human personality on the basis of a recently developed complex hierarchical model of temperament and character.. Int J Psychiatry Clin Pract. 1-14.
Tsiouda, T., Sardeli C., Porpodis K., Pilikidou M., Apostolidis G., Kyrka K., et al. (2020).  Sex Differences and Adverse Effects between Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer.. J Cancer. 11(11), 3407-3415.
Gebhard, C., Messerli M., Lohmann C., Treyer V., Bengs S., Benz D. C., et al. (2018).  Sex and age differences in the association of heart rate responses to adenosine and myocardial ischemia in patients undergoing myocardial perfusion imaging.. J Nucl Cardiol.
Tsaousi, G., Pourzitaki C., & Amaniti E. (2015).  Sevoflurane induction of anesthesia for a large epiglottic cyst removal when awake intubation is not an option.. Hippokratia. 19(1), 94.
Nikolaou, K., Kapoukranidou D., Ndungu S., Floros G., & Kovatsi L. (2017).  Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal.. J Psychoactive Drugs. 49(3), 233-241.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές